dc.contributor.author |
OBEAGU, Emmanuel I. |
|
dc.contributor.author |
OBEAGU, Getrude U. |
|
dc.contributor.author |
GAMDE, Solomon M. |
|
dc.contributor.author |
CHINDO, Ishaya E. |
|
dc.contributor.author |
ADIKE, Calista N. |
|
dc.contributor.author |
RAMOS, Gina F. |
|
dc.date.accessioned |
2024-02-20T14:24:57Z |
|
dc.date.available |
2024-02-20T14:24:57Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
2349-8870 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/123456789/990 |
|
dc.description.abstract |
Iron deficiency anaemia is a critical condition in pregnancy which may not easily be predicted. It has caused a lot
of havocs to the mothers and the babies. A widespread health issue that primarily affects pregnant women is iron
deficiency anemia. Pregnancy-related iron deficiency anemia is linked to higher rates of maternal and perinatal
morbidity and mortality. Infant neurocognitive deficits may also be linked to maternal iron deficiency. Hepcidin,
the principal regulator of iron homeostasis, influences the rise in iron requirements that occur during pregnancy.
The persistent prevalence of maternal anemia worldwide suggests that current methods of iron supplementation
are ineffective. The dose and frequency of oral iron administration may be changed to increase therapeutic
effectiveness in light of recent advances in our understanding of systemic and placental iron homeostasis. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
European Journal of Biomedical and Pharmaceutical sciences |
en_US |
dc.relation.ispartofseries |
VOLUME 10;9 |
|
dc.subject |
Pregnancy |
en_US |
dc.subject |
Iron |
en_US |
dc.subject |
Iron deficiency anaemia |
en_US |
dc.subject |
Anaemia |
en_US |
dc.subject |
Maternal outcome |
en_US |
dc.subject |
Hepcidin. |
en_US |
dc.title |
IRON DEFICIENCY ANAEMIA: ENEMICAL TO PREGNANCY |
en_US |
dc.type |
Article |
en_US |